Yang D, Xu G, Ding H, Zhong L, et al. Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer. Cancer Chemother Pharmacol 2024 Jul 31. doi: 10.1007/s00280-024-04702.
PMID: 39080018